These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 33300324)
21. The use of early neuromuscular blockage in acute respiratory distress syndrome: A systematic review and meta-analyses of randomized clinical trials. Savoie-White FH; Tremblay L; Menier CA; Duval C; Bergeron F; Tadrous M; Tougas J; Guertin JR; Ugalde PA Heart Lung; 2023; 57():186-197. PubMed ID: 36242824 [TBL] [Abstract][Full Text] [Related]
22. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey. Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426 [TBL] [Abstract][Full Text] [Related]
23. Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Ho ATN; Patolia S; Guervilly C J Intensive Care; 2020; 8():12. PubMed ID: 32015880 [TBL] [Abstract][Full Text] [Related]
24. [Statin in the treatment of ALI/ARDS: a systematic review and Meta-analysis based on international databases]. Chen M; Lu J; Chen Q; Cheng L; Geng Y; Jiang H; Wang X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):51-56. PubMed ID: 28459404 [TBL] [Abstract][Full Text] [Related]
26. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347 [TBL] [Abstract][Full Text] [Related]
27. Application of Neuromuscular Blockers in Patients with ARDS in ICU: A Retrospective Study Based on the MIMIC-III Database. Pan X; Liu J; Zhang S; Huang S; Chen L; Shen X; Chen D J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902664 [TBL] [Abstract][Full Text] [Related]
28. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome. Macario A; Chow JL; Dexter F BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706 [TBL] [Abstract][Full Text] [Related]
29. Early Paralysis for the Management of ARDS. Grawe ES; Bennett S; Hurford WE Respir Care; 2016 Jun; 61(6):830-8. PubMed ID: 27094392 [TBL] [Abstract][Full Text] [Related]
30. Prone position for acute respiratory failure in adults. Bloomfield R; Noble DW; Sudlow A Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008095. PubMed ID: 26561745 [TBL] [Abstract][Full Text] [Related]
31. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). Chacko B; Peter JV; Tharyan P; John G; Jeyaseelan L Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008807. PubMed ID: 25586462 [TBL] [Abstract][Full Text] [Related]
32. Association between neuromuscular blocking agents and the development of intensive care unit-acquired weakness (ICU-AW): A systematic review with meta-analysis and trial sequential analysis. Bellaver P; Schaeffer AF; Leitao CB; Rech TH; Nedel WL Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101202. PubMed ID: 36804373 [TBL] [Abstract][Full Text] [Related]
33. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient. deBacker J; Hart N; Fan E Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334 [TBL] [Abstract][Full Text] [Related]
34. [The effect of neuromuscular blocking agents on prognosis of patients with acute respiratory distress syndrome: a meta analysis]. Wang AT; Gao JL; Li XL; Leng YX; Yao ZY; Zhu X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Mar; 25(3):149-53. PubMed ID: 23656767 [TBL] [Abstract][Full Text] [Related]
35. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Arroliga AC; Thompson BT; Ancukiewicz M; Gonzales JP; Guntupalli KK; Park PK; Wiedemann HP; Anzueto A; Crit Care Med; 2008 Apr; 36(4):1083-8. PubMed ID: 18401254 [TBL] [Abstract][Full Text] [Related]
36. Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Zhu D; Zhang Y; Li S; Gan L; Feng H; Nie W Intensive Care Med; 2014 Apr; 40(4):504-12. PubMed ID: 24556914 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study. Haeberle H; Prohaska S; Martus P; Straub A; Zarbock A; Marx G; Zago M; Giera M; Koeppen M; Rosenberger P Trials; 2020 Mar; 21(1):242. PubMed ID: 32131881 [TBL] [Abstract][Full Text] [Related]
38. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome]. Lyu G; Wang X; Jiang W; Cai T; Zhang Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261 [TBL] [Abstract][Full Text] [Related]
39. Neuromuscular Blockade Monitoring in Acute Respiratory Distress Syndrome: Randomized Controlled Trial of Clinical Assessment Alone or With Peripheral Nerve Stimulation. Rezaiguia-Delclaux S; Laverdure F; Genty T; Imbert A; Pilorge C; Amaru P; Sarfati C; Stéphan F Anesth Analg; 2021 Apr; 132(4):1051-1059. PubMed ID: 33002927 [TBL] [Abstract][Full Text] [Related]